Treatments for Vitiligo
DOI:
https://doi.org/10.47611/jsrhs.v11i1.2469Keywords:
vitiligo, treatments, JAK Inhibitors, oral, topical, phototherapy, NBUVB phototherapy, PUVA phototherapyAbstract
Vitiligo is a skin condition that leads to skin depigmentation in irregular patterns with potentially severe esthetic and psychological effects on the affected individual. While its etiology is not well understood, it seems to be a multifactorial condition that may be caused by hereditary factors and autoimmune processes among others. By reviewing various publications found through different databases like PubMed and GoogleScholar, this paper summarizes the different therapeutic options available for vitiligo. This includes JAK inhibitors, both topical and oral, and other types of topical drugs, such as vitamin D, calcineurin inhibitors, and steroids. There are also various phototherapy techniques, which all utilize ultraviolet (UV) light. Phototherapy devices are able to deliver the wavelengths that are most beneficial for the stimulation of repigmentation through special filtering. These different treatments give hope to millions of individuals afflicted by this condition worldwide. The following paper overviews and compares the different JAK inhibitors, other topical drugs, and phototherapy options available to treat vitiligo.
Downloads
References or Bibliography
Agarwal, P.; Rashighi, M.; Essien, K. I.; et al. (2015). Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. The Journal of investigative dermatology, 135(4), 1080–1088. https://doi.org/10.1038/jid.2014.529
Bae, J.M.; Jung, H.M.; Hong B.Y.; et al. (2017). Phototherapy for Vitiligo: A Systematic Review and Meta-analysis. JAMA Dermatology, 153(7):666–674. DOI: 10.1001/jamadermatol.2017.0002
Bae J.M. Ju, H.J. Lee, R.W. (2020). Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy. JAMA Dermatology, 156(5):529–537. https://doi.org/10.1001/jamadermatol.2020.0218
Bergqvist, C., & Ezzedine, K. (2020). Vitiligo: A review. Dermatology. 236:571–592 https://doi.org/10.1159/000506103
Damsky, W. & King, BA. (2017). Jak inhibitors in dermatology: The promise of a new drug class. Journal of the American Academy of Dermatology, 76(4):736-744. doi: 10.1016/j.jaad.2016.12.005.
Ezzedine, K. & Silverberg, N. (2016). A Practical Approach to the Diagnosis and Treatment of Vitiligo in Children. Pediatrics, 138(1):e20154126. https://doi.org/10.1542/peds.2015-4126
Ibbotson S. H. (2018). A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy. Frontiers in medicine, 5:184. https://doi.org/10.3389/fmed.2018.00184
Relke, N. & Gooderham, M. (2019). The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature. Journal of Cutaneous Medicine and Surgery, 23(3):298-306. https://doi.org/10.1177/1203475419833609
Rodrigues, M. Ezzedine, K. Hamzavi, I. Pandya, AG. & Harris, JE; Vitiligo Working Group (2017). New discoveries in the pathogenesis and classification of vitiligo. Journal of the American Academy of Dermatology, 77(1):1-13. DOI: 10.1016/j.jaad.2016.10.048
Rork, J. F., Rashighi, M., & Harris, J. E. (2016). Understanding autoimmunity of vitiligo and alopecia areata. Current opinion in pediatrics, 28(4), 463–469. https://doi.org/10.1097/MOP.0000000000000375
Rothstein, B.; Joshipura, D.; Saraiya, A.; et al. (2017). Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib. Journal of the American Academy of Dermatology, 76(6):1054-1060.e1.https://doi.org/10.1016/j.jaad.2017.02.049
Samaka, R. M. Basha, M. A. & Menesy, D. (2019). Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo. Clinical, cosmetic and investigational dermatology, 12: 469–480. https://doi.org/10.2147/CCID.S210106
Solimani, F. Meier, K, & Ghoreschi, K. (2019). Emerging Topical and Systemic JAK Inhibitors in Dermatology. Frontiers in immunology, 10:2847. https://doi.org/10.3389/fimmu.2019.02847
Sonthalia, S. Aggarwal, P. (2018). Oral tofacitinib: Contemporary appraisal of its role in dermatology. Indian Dermatology Online J, 10(5): 503–518. doi: 10.4103/idoj.IDOJ_474_18
Published
How to Cite
Issue
Section
Copyright (c) 2023 Sarah Alami; Grace Lee, Julie Song
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
